Log In
Tuesday 21st November 2017

NICE decision-making needs scrutiny

19th December 2008

The Royal College of Nursing has said that there needs to be a proper debate on changes to the NHS's approach to resource allocation.

The RCN said that it agrees that the National Institute for Health and Clinical Excellence (NICE) should place more value on medicines that extend life or treat terminal conditions. The views have been set out in the college’s response to NICE's consultation on appraising end-of-life medicines where it says that more debate is required on factors important to patients in making resource allocation decisions.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2017